Antibiotic Resistance in Canada at the Dawn of the New Millennium - a Model for the Developed World?

Overview

Journal Can J Infect Dis

Date 2007 Dec 27

PMID 18159295

Citations 3

Authors

J M Conly

B L Johnston

Affiliations

Soon will be listed here.

Citing Articles

Drivers of Antibiotic Resistance Transmissionin Low- and Middle-Income Countriesfrom a "One Health" Perspective-A Review.

Iskandar K, Molinier L, Hallit S, Sartelli M, Catena F, Coccolini F Antibiotics (Basel). 2020; 9(7).

PMID: 32630353 PMC: 7400606. DOI: 10.3390/antibiotics9070372.

The costs and consequences of methicillin-resistant Staphylococcus aureus infection treatments in Canada.

Rosner A, Becker D, Wong A, Miller E, Conly J Can J Infect Dis Med Microbiol. 2007; 15(4):213-20.

PMID: 18159495 PMC: 2094976. DOI: 10.1155/2004/383461.

A retrospective analysis of practice patterns in the treatment of methicillin-resistant Staphylococcus aureus skin and soft tissue infections at three Canadian tertiary care centres.

Conly J, Stiver H, Weiss K, Becker D, Rosner A, Miller E Can J Infect Dis. 2007; 14(6):315-21.

PMID: 18159474 PMC: 2094957. DOI: 10.1155/2003/103682.

References

Voss A, Milatovic D, Rosdahl V, Braveny I . Methicillin-resistant Staphylococcus aureus in Europe. Eur J Clin Microbiol Infect Dis. 1994; 13(1):50-5. DOI: 10.1007/BF02026127. View

Wang E, Einarson T, Kellner J, Conly J . Antibiotic prescribing for Canadian preschool children: evidence of overprescribing for viral respiratory infections. Clin Infect Dis. 1999; 29(1):155-60. DOI: 10.1086/520145. View

SWARTZ M . Use of antimicrobial agents and drug resistance. N Engl J Med. 1997; 337(7):491-2. DOI: 10.1056/NEJM199708143370709. View

Martone W . Spread of vancomycin-resistant enterococci: why did it happen in the United States?. Infect Control Hosp Epidemiol. 1998; 19(8):539-45. DOI: 10.1086/647870. View

Panlilio A, Culver D, Gaynes R, Banerjee S, Henderson T, Tolson J . Methicillin-resistant Staphylococcus aureus in U.S. hospitals, 1975-1991. Infect Control Hosp Epidemiol. 1992; 13(10):582-6. DOI: 10.1086/646432. View

Hutchinson J, Foley R . Method of physician remuneration and rates of antibiotic prescription. CMAJ. 1999; 160(7):1013-7. PMC: 1230193. View

Lior L, Litt M, Hockin J, Kennedy C, Jolley B, Garcia M . Vancomycin-resistant enterococci on a renal ward in an Ontario hospital. Can Commun Dis Rep. 1996; 22(15):125-8. View

. Nosocomial enterococci resistant to vancomycin--United States, 1989-1993. MMWR Morb Mortal Wkly Rep. 1993; 42(30):597-9. View

. Controlling antimicrobial resistance. An integrated action plan for Canadians. Can Commun Dis Rep. 2001; 23 Suppl 7:i-iv, 1-32, i-iv, 1-32. View

10.

Simor A, Ofner-Agostini M, Paton S . The Canadian Nosocomial Infection Surveillance Program: results of the first 18 months of surveillance for methicillin-resistant Staphylococcus aureus in Canadian hospitals. Can Commun Dis Rep. 1997; 23(6):41-5. View

11.

Stewart J, Pilla J, Dunn L . Pilot study for appropriate anti-infective community therapy. Effect of a guideline-based strategy to optimize use of antibiotics. Can Fam Physician. 2000; 46:851-9. PMC: 2144801. View

12.

Goldmann D, Weinstein R, Wenzel R, Tablan O, DUMA R, Gaynes R . Strategies to Prevent and Control the Emergence and Spread of Antimicrobial-Resistant Microorganisms in Hospitals. A challenge to hospital leadership. JAMA. 1996; 275(3):234-40. View

13.

Levine M, Pradhan A . Can the health care system buy better antibiotic prescribing behaviour?. CMAJ. 1999; 160(7):1023-4. PMC: 1230196. View

14.

Preston M, Borczyk A, Jamieson F . Epidemic methicillin-resistant Staphylococcus aureus strain--Ontario. Can Commun Dis Rep. 1998; 24(6):47-9. View

15.

Kunin C . Resistance to antimicrobial drugs--a worldwide calamity. Ann Intern Med. 1993; 118(7):557-61. DOI: 10.7326/0003-4819-118-7-199304010-00011. View

16.

Ofner-Agostini M, Conly J, Paton S, Kureishi A, Nicolle L, Mulvey M . Vancomycin-resistant enterococci (VRE) in Canada - Results of the Canadian Nosocomial Infection Surveillance Program 1996 VRE point prevalence surveillance project. Can J Infect Dis. 2012; 8(2):73-8. PMC: 3327345. DOI: 10.1155/1997/297038. View

17.

. Report of the ASM task force on antibiotic resistance. Antimicrob Agents Chemother. 1995; Suppl:1-23. View

18.

Simor A, Augustin A, Ng J, Betschel S, McArthur M . Control of MRSA in a long-term care facility. Infect Control Hosp Epidemiol. 1994; 15(2):69-70. DOI: 10.1086/646861. View

19.

Simor A, Louie M, Low D . Canadian national survey of prevalence of antimicrobial resistance among clinical isolates of Streptococcus pneumoniae. Canadian Bacterial Surveillance Network. Antimicrob Agents Chemother. 1996; 40(9):2190-3. PMC: 163497. DOI: 10.1128/AAC.40.9.2190. View

20.

. Addressing emerging infectious disease threats: a prevention strategy for the United States. Executive summary. MMWR Recomm Rep. 1994; 43(RR-5):1-18. View